Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Eric A Hughes is See "Remarks" at Teva Pharmaceutical Industries. OQRO lists 5 transactions filed with the SEC under this name, the latest on Aug 5, 2025, each linked to the official Form 4.
See "Remarks"
Disclosures on record
5
Companies involved
1
Teva Pharmaceutical IndustriesTEVA
5 disclosures · Mar 2025 – Aug 2025 · 5 sold
Aug 1, 2025Sold~$799Kdisclosed Aug 5
DetailsOfficial recordMar 4, 2025Sold~$239Kdisclosed Mar 6
DetailsMar 5, 2025Sold~$129Kdisclosed Mar 6
DetailsOfficial recordMar 3, 2025Sold~$319Kdisclosed Mar 5
DetailsOfficial recordMar 4, 2025Sold~$80Kdisclosed Mar 5
DetailsOfficial recordEric A Hughes has no open-market purchase on record since 2023. Sales in each of the last 3 years.
Eric A Hughes reported 0 open-market purchases and 9 sales since 2023; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | $1.57M5×5 trades |
| 2024 | — | $1.31M3×3 trades |
| 2023 | — | $438K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Eric A Hughes has no open-market purchase on record since 2023. Sales in each of the last 3 years.
In SEC filings since 2023: no open-market purchase is on record; the latest open-market sale is from 2025.
Teva Pharmaceutical Industries (TEVA), from 2023 to 2025: 0 purchases and 9 sales.
Eric A Hughes reported 0 open-market purchases and 9 sales here, 2023 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
